News
UNDER TECHNOLOGY | Canadian researchers on promising path towards developing flu treatment using lipid target
How can we help our immune system to balance the two main host defense strategies: attacking pathogens (called host resistance) and preserving our own tissue (called disease tolerance)? Dr. Erwan Pernet and Dr. Maziar Divangahi from te Research Institute of the McGill University Health Centre (RI-MUHC), have identified a lipid target to “tone down” the hyper-active immunity to influenza infection. Image credit: McGill University Health Centre
A team of scientists of the Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal, Canada, has tackled this fundamental question and recently identified a target to “tone down” the hyper-active immunity to influenza infection.